3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other hematologic neoplasm
1
Lymphoid
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Neoplasm Metastasis
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
pembrolizumab
35
Nivolumab
14
Docetaxel
11
atezolizumab
10
Paclitaxel
9
Carboplatin
7
Gemcitabine
6
Cisplatin
6
Trastuzumab
5
Magnetic Resonance Spectroscopy
5
Ipilimumab
5
Fluorodeoxyglucose F18
5
Cyclophosphamide
5
Bevacizumab
5
fludarabine
4
avelumab
4
Specimen Handling
4
Psychiatric Rehabilitation
4
Oxaliplatin
4
Leucovorin
4
Fluorouracil
4
Albumin-Bound Paclitaxel
4
130-nm albumin-bound paclitaxel
4
cemiplimab
3
Taxes
3
Polymerase Chain Reaction
3
Pemetrexed
3
Irinotecan
3
Gene Expression Profiling
3
Early Intervention, Educational
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Tissue Banks
×
Genitourinary
×
Clear all
NCT06827639
2025-02-14
FUTURE
Assistance Publique Hopitaux De Marseille
Not yet recruiting
640 enrolled